AL Amyloidosis (AL): Clinical Trials

3 trials for AL Amyloidosis (AL), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 enrolling by invitation. 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Phase 21Recruiting 1

Follow AL Amyloidosis (AL): new trials by email Literature Review of AL Amyloidosis (AL) trials Research Report on AL Amyloidosis (AL)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
sonrotoclax, Daratumumab, Dexamethasone - AL Amyloidosis (AL), t(11;14) Positive
Phase 2RecruitingPeking University People's Hospital392026-02-102026-07-28
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
Metabolically Armed BCMA CAR-T cells. - Multiple Myeloma (MM), Plasma Cell Leukemia (PCL)
Early Phase 1RecruitingAnhui Provincial Hospital362025-06-232025-07-25
Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis
AL Amyloidosis (AL), Cardiac Amyloidosis
Enrolling by invitationBeijing Anzhen Hospital492025-02-132026-09-10

Narrower conditions

Immunoglobulin Light-chain Amyloidosis (3)  ·  Amyloid Neuropathies, Familial (1)  ·  Leukemia, Plasma Cell (1)  ·  Multiple Myeloma (1)

Broader conditions

Amyloidosis (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphoproliferative Disorders (3)  ·  Metabolic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Plasma Cell (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Paraproteinemias (3)  ·  Proteostasis Deficiencies (3)  ·  Amyloid Neuropathies (1)  ·  Amyloidosis, Familial (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)

Interventions

Dexamethasone (1)  ·  daratumumab (1)

Sponsors

Anhui Provincial Hospital (1)  ·  Beijing Anzhen Hospital (1)  ·  Peking University People's Hospital (1)

Countries

China (3)